Clinakos at ML@B Career Fair
Thank you University of California, Berkeley and Machine Learning at Berkeley for inviting Clinakos Inc. to recruit for open positions at the 2023 UC Berkeley-ML@B Career Fair. It was an amazing experience to discuss #AI, #ML and #GenerativeAI with some of the smartest AI/ML brains in the world. Over 100 recent graduate and undergraduate students […]
Thoughts on EDS Patient Story
Stephanie Aston, 33, died at her New Zealand home on September 1 after a public battle with Ehlers-Danlos Syndrome (EDS) — a genetic disorder she was accused of faking. Stephanie had a family history of EDS, a serious disorder associated with connective tissues. Unfortunately, Stephanie was accused by her physician of faking her symptoms. Instead […]
Patient Data: Emerging Opportunities for Rare Diseases, Cell & Gene Therapies and Oncology
Patient data has the potential to transform all aspects of life sciences product development and commercialization. In this session, you will hear from the CEO of a cell and gene therapy company with a late-stage investigational therapeutic for a rare disease. He will present his perspectives on how patient data can be transformative for rare […]
Clinakos Celebrates Rare Disease Day
Over 300 million people worldwide are affected by rare diseases. Rare diseases impact the lives of people of all races, religions, and socio-economic status. Clinakos is proud to support the Rare Disease Patients and Life science partners in developing and commercializing cures via our unique data & solution offerings for >700 Rare, Oncology and Non-Rare […]
Meet us at JPMorgan Chase & Co.’s 41st Annual JP Morgan Healthcare Conference
Meet Clinakos Inc. at JPMorgan Chase & Co.‘s 41st Annual JP Morgan Healthcare Conference in San Francisco. Our team is here till Thursday Jan 12th meeting with clients, partners and anyone else who shares our vision of democratizing patient data for research and patient car.
Meet us at HLTH 2022
Meet Clinakos Inc. at HLTH2022 to learn about how recent regulation changes provide an opportunity for Pharmaceutical Companies to leverage patient data for multiple use cases. If you are attending and want to meet, please email sales@clinakos.com
Clinakos Spreads Breast Cancer Awareness day
Over 300 million people worldwide are affected by rare diseases. Rare diseases impact the lives of people of all races, religions, and socio-economic status. Clinakos is proud to support the Rare Disease Patients and Life science partners in developing and commercializing cures via our unique data & solution offerings for >700 Rare, Oncology and Non-Rare […]
A New Paradigm of Patient Level Data
Deep, Real-Time, and actual Patient Level Data are changing how Pharma and Biotech companies are developing and commercializing products. In this new world, Patient and Physician journeys are dynamic. Patient drop-offs and abandonments are handled via smart AI models powered by actual patient data. We at Clinakos Inc. are proud to be at the center […]
Clinakos is proud to enable Patient Level Data for our large and small pharma clients
Patient Level Data especially in oncology and rare diseases provides a unique opportunity for pharmaceutical franchise leaders and launch teams. Access to hard-to-find patient populations tying qualitative and quantitative research to real-time linked patient-level medical records including EMR, Lab, Pharmacy, and SODH is key to taking important decisions pre, peri, and post-launch. With patient adoption […]
Clinakos Inc. partners with Rare Patient Voice to provide unique offering
Clinakos Inc. is extremely proud to share our capabilities with Wes Michael and his team at Rare Patient Voice to provide this one of kind offering for our pharmaceutical and biotech clients.
